8:14 AM ET
Form 4
Insider Buying
Lexicon Pharmaceuticals CEO Michael Exton Buys $50K of Stock
Michael Exton, CEO, bought 30,064 shares of Lexicon Pharmaceuticals, Inc. at $1.66 a share, worth $50K in total on Nov 6, 2026. Shares held after the trade: 328,496 (+10.1%).
- Value
- $50K
- Shares
- 30,064
- Price
- $1.66
- Role
- CEO
- Holding change
- +10.1%
- Trade date
- Nov 6, 2026